These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32916183)

  • 1. Considerations in developing medical countermeasures against chemical ocular toxicity.
    Yeung DT; Araj H; Harper JR; Platoff GE
    Toxicol Lett; 2020 Nov; 334():1-3. PubMed ID: 32916183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)-August 6/7, 2019.
    Yeung DT; Bough KJ; Harper JR; Platoff GE
    J Med Toxicol; 2020 Jan; 16(1):87-105. PubMed ID: 31853736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The National Institutes of Health Chemical Countermeasures Research Program (NIH CCRP): A collaborative opportunity to develop effective and accessible chemical medical countermeasures for the American people.
    Yeung DT; Harper JR; Platoff GE
    Drug Dev Res; 2020 Dec; 81(8):907-910. PubMed ID: 32573018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Product Development within the National Institutes of Health Radiation and Nuclear Countermeasures Program.
    Cassatt DR; DiCarlo AL; Molinar-Inglis O
    Radiat Res; 2024 May; 201(5):471-478. PubMed ID: 38407357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIAID/NIH radiation/nuclear medical countermeasures product research and development program.
    Hafer N; Cassatt D; Dicarlo A; Ramakrishnan N; Kaminski J; Norman MK; Maidment B; Hatchett R
    Health Phys; 2010 Jun; 98(6):903-5. PubMed ID: 20445403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supporting Fundamental Chemical Toxicology Research To Inform Medical Countermeasure Developments: The National Institutes of Health Chemical Countermeasures Research Program.
    Yeung DT; Harper JR; Platoff GE
    Chem Res Toxicol; 2020 Apr; 33(4):855-859. PubMed ID: 32196324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIH Policies and Regulatory Pathways to U.S. FDA licensure: Strategies to Inform Advancement of Radiation Medical Countermeasures and Biodosimetry Devices.
    Satyamitra MM; Perez-Horta Z; DiCarlo AL; Cassatt DR; Rios CI; Price PW; Taliaferro LP
    Radiat Res; 2022 May; 197(5):533-553. PubMed ID: 35113982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Office of the Assistant Secretary for Preparedness and Response; HHS Public Health Emergency Medical Countermeasures Enterprise implementation plan for chemical, biological, radiological and nuclear threats. Notice.
    Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services
    Fed Regist; 2007 Apr; 72(77):20117-28. PubMed ID: 17520758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NIH Countermeasures Against Chemical Threats Program: overview and special challenges.
    Jett DA
    Ann N Y Acad Sci; 2016 Jun; 1374(1):5-9. PubMed ID: 27398820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations on How to Manage Anticipated Communication Dilemmas Involving Medical Countermeasures in an Emergency.
    Schoch-Spana M; Brunson E; Chandler H; Gronvall GK; Ravi S; Sell TK; Shearer MP
    Public Health Rep; 2018; 133(4):366-378. PubMed ID: 29847750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Medical Countermeasures in Small-Scale Emergency Responses.
    Perry IA; Noe RS; Stewart A
    Am J Public Health; 2018 Sep; 108(S3):S196-S201. PubMed ID: 30192656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Biomarkers for Radiation Biodosimetry and Medical Countermeasures Research: Current Status, Utility, and Regulatory Pathways.
    Satyamitra MM; DiCarlo AL; Hollingsworth BA; Winters TA; Taliaferro LP
    Radiat Res; 2022 May; 197(5):514-532. PubMed ID: 34879151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES BIODOSIMETRY AND RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE PROGRAMS.
    Homer MJ; Raulli R; DiCarlo-Cohen AL; Esker J; Hrdina C; Maidment BW; Moyer B; Rios C; Macchiarini F; Prasanna PG; Wathen L
    Radiat Prot Dosimetry; 2016 Sep; 171(1):85-98. PubMed ID: 27590469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NIAID Radiation Countermeasures Program business model.
    Hafer N; Maidment BW; Hatchett RJ
    Biosecur Bioterror; 2010 Dec; 8(4):357-63. PubMed ID: 21142762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Planning Considerations for State, Local, Tribal, and Territorial Partners to Receive Medical Countermeasures From CDC's Strategic National Stockpile During a Public Health Emergency.
    Bhavsar TR; Esbitt DL; Yu PA; Yu Y; Gorman SE
    Am J Public Health; 2018 Sep; 108(S3):S183-S187. PubMed ID: 30192668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring and Assessment of Medical Countermeasures as Part of a Public Health Emergency Response.
    Measer GT; Maher CT; Hu-Primmer J
    Am J Public Health; 2018 Sep; 108(S3):S224-S226. PubMed ID: 30192659
    [No Abstract]   [Full Text] [Related]  

  • 17. Building the strategic national stockpile through the NIAID Radiation Nuclear Countermeasures Program.
    Rios CI; Cassatt DR; Dicarlo AL; Macchiarini F; Ramakrishnan N; Norman MK; Maidment BW
    Drug Dev Res; 2014 Feb; 75(1):23-8. PubMed ID: 24648046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency planning and preparedness for the deliberate release of toxic industrial chemicals.
    Russell D; Simpson J
    Clin Toxicol (Phila); 2010 Mar; 48(3):171-6. PubMed ID: 20334545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Countermeasures for Preventing and Treating Opioid Overdose.
    France CP; Ahern GP; Averick S; Disney A; Enright HA; Esmaeli-Azad B; Federico A; Gerak LR; Husbands SM; Kolber B; Lau EY; Lao V; Maguire DR; Malfatti MA; Martinez G; Mayer BP; Pravetoni M; Sahibzada N; Skolnick P; Snyder EY; Tomycz N; Valdez CA; Zapf J
    Clin Pharmacol Ther; 2021 Mar; 109(3):578-590. PubMed ID: 33113208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical countermeasures for platelet regeneration after radiation exposure. Report of a workshop and guided discussion sponsored by the National Institute of Allergy and Infectious Diseases, Bethesda, MD, March 22–23, 2010.
    DiCarlo AL; Poncz M; Cassatt DR; Shah JR; Czarniecki CW; Maidment BW
    Radiat Res; 2011 Jul; 176(1):e0001-15. PubMed ID: 21545291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.